Supporting cancer care clinicians to 'hold' their patients during and beyond the COVID-19 pandemic: a role for reflective ethics discussions.

COVID-19 cancer care clinicians clinical ethics holding patients moral distress

Journal

Internal medicine journal
ISSN: 1445-5994
Titre abrégé: Intern Med J
Pays: Australia
ID NLM: 101092952

Informations de publication

Date de publication:
Jul 2021
Historique:
revised: 14 04 2021
received: 11 10 2020
accepted: 12 05 2021
entrez: 19 7 2021
pubmed: 20 7 2021
medline: 22 7 2021
Statut: ppublish

Résumé

The COVID-19 pandemic has placed an overwhelming burden on healthcare delivery globally. This paper examines how COVID-19 has affected cancer care clinicians' capacity to deliver cancer care in the Australian context. We use the lens of 'holding patients' (drawing from attachment theory, psychology and from Australian Indigenous knowledge) to conceptualise cancer clinicians' processes of care and therapeutic relationships with patients. These notions of 'holding' resonate with the deep responsibility cancer care clinicians feel towards their patients. They enrich ethical language beyond duties to benefit, avoid harm, respect patients' autonomy and provide just treatment. We consider the disruptive effects of COVID-19 on care delivery and on clinicians themselves. We then show how models of clinical ethics and other similar reflective discussion approaches are a relevant support mechanism to assist clinicians to process and make sense of COVID-19's disruptions to their professional ethical role of holding patients during and beyond the pandemic.

Identifiants

pubmed: 34278682
doi: 10.1111/imj.15375
pmc: PMC8447295
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1143-1145

Informations de copyright

© 2021 Royal Australasian College of Physicians.

Références

Int J Psychoanal. 1991;72 ( Pt 4):709-18
pubmed: 1797723
Intern Med J. 2020 Oct;50(10):1282-1285
pubmed: 32951279
Psychooncology. 2005 Oct;14(10):887-98; discussion 899-900
pubmed: 16200520
Gynecol Oncol. 2020 Sep;158(3):526-530
pubmed: 32622474
Hastings Cent Rep. 2021 Jan;51(1):22-27
pubmed: 33630324
Med Educ. 2017 Mar;51(3):258-268
pubmed: 27995660
J Natl Cancer Inst Monogr. 2010;2010(40):72-80
pubmed: 20386055
J Med Philos. 2015 Feb;40(1):102-20
pubmed: 25503608

Auteurs

Clare Delany (C)

Department of Medical Education, Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia.

Joanne Benhamu (J)

Cancer Clinical Trials Unit, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Rosalind McDougall (R)

Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.

Danielle Ko (D)

Palliative Care, Austin Health, Melbourne, Victoria, Australia.

Hayley Jones (H)

McCabe Centre for Law & Cancer, Melbourne, Victoria, Australia.

Linda Mileshkin (L)

Cancer Clinical Trials Unit, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Geraldine Largey (G)

Southern Health Integrated Cancer Services, Monash Health, Melbourne, Victoria, Australia.

Alex Clinch (A)

Cancer Clinical Trials Unit, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Sarah Heynemann (S)

Palliative Care, Austin Health, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH